The pathogenic mechanism was elucidated by demonstrating, for the first time, that VPA binds to KEAP1, causing NRF2 to migrate to the nucleus and subsequently activate the transcription of FATP2, ultimately increasing fatty acid uptake, which triggers hepatic steatosis. Here, KEAP1 is linked to fatty liver disease.